Vote Now
Alzheimer's Biomarker Standardization | Research Center | Alzheimer's Association


Alzheimer's Assocation Research only
All of alz.org
  • Go to Alz.org
  • Research Center
  • AAIC
  • ISTAART
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Home
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Global Biomarker Standardization Consortium (GBSC)


CONSORTIUM OVERVIEW GBSC WORKING GROUPS RELATED PROJECTS  

The Alzheimer's Association has established the Global Consortium for Biomarker Standardization to gather key researchers, clinicians, and industry, regulatory and government leaders in Alzheimer's disease to achieve consensus on the best ways to standardize and validate biomarker tests for use in clinical practices around the world.

About the Global Consortium


Next Meeting

September 23, 2014
9 A.M. CDT

Contact Meredith.mcneil@alz.org for more information.

In the past few years, the Alzheimer's disease research enterprise has developed improved techniques and technologies aimed at early diagnosis and detection of Alzheimer's disease. The field has seen remarkable growth in research using  clinical assessment, psychometric testing, cerebrospinal fluid-based biomarkers, magnetic resonance imaging (MRI) measurements of  brain volume, and molecular imaging of beta-amyloid in the brain to diagnose Alzheimer's at its earliest stages.

Before these and other diagnostic measures can be incorporated into clinical practice worldwide, they must be standardized and validated on a global scale. The Global Consortium for Biomarker Standardization brings together these experts in teleconference and face-to-face meetings to address the challenges inherent in this goal and to develop the global scales required for worldwide implementation.

Related Projects


The Global Consortium for Biomarker Standardization will continue to grow and expand as the field identifies novel technologies and techniques for diagnosis of Alzheimer's disease. To date, there are projects addressing:

Related papers and abstracts


For more information


For investigators who are interested in more information on the Global Consortium, including associated projects, past meetings or future meetings, please contact Maria C. Carrillo, Ph.D.

Maria C. Carrillo, Ph.D.
Vice President, Medical & Scientific Relations
Alzheimer's Association
maria.carrillo@alz.org